newsfilter
← Latest News
PR Newswire·

Leap Therapeutics to Present at B. Riley Securities' 3rd Annual Oncology Conference

CAMBRIDGE, Mass., Jan. 11, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi,